Effect of nano extracts of olea europaea leaves, ficus carica and liraglutide in lipidemic liver of type 2 diabetic rat model

被引:4
|
作者
Alalwani, Aisha D. [1 ]
Hummdi, Laila A. [1 ]
Qahl, Safa H. [1 ]
机构
[1] Univ Jeddah, Sci Coll, Dept Biol, Asfan, Saudi Arabia
关键词
Ficus carica; Olea europaea; Diabetic rats; Lipid profile; Hepatic histopathology; L;
D O I
10.1016/j.sjbs.2022.103333
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The study aimed to evaluate the impact of Ficus carica mixture and Olea europaea leaf nano extracts, and liraglutide, on liver tissue and serum lipids in type 2 diabetic male albino rat model. Forty rats were divided equally into 4 groups were used. Group 1 was the non-diabetic control group. The animals in Groups 2-4 was injected intraperitoneally with a single dose of 60 mg/kg b.w. Streptozotocin to induce a diabetic rat model. Group 2 served as a positive control for diabetes. 0.02 mg/kg b.w./day of Liraglutide gave to groups 3 and 4 and 4.8 ng/ml x 105 b.w./day of a mixture of the nano extracts, respectively. Eight weeks after treatment, the animals were sacrificed. Blood was collected for glucose analysis and serum low-density lipoprotein, high-density lipoprotein, total cholesterol, and triglycerides analysis, and the livers processed for histopathological examination. The elevated lipid profiles and blood glucose levels in diabetic group (Group 2) were significantly reduced (p < 0.001) following the administration of liraglutide and nano extracts in Groups 3 and 4. Progressive fatty acid changes were found in the liver sections, indicated by the deposition of various sizes of lipid droplets in most liver lobules, along with patchy hepatocyte necrosis. These pathological changes were ameliorated in the liraglutide-and nano-extract treated rats. Treatment with the nano extracts resulted in significant power assays associated with recovery of hepatic histology and functional alterations, compared to liraglutide treatment.(c) 2022 Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Liraglutide ameliorates early renal injury by the activation of renal FoxO1 in a type 2 diabetic kidney disease rat model
    Chen, Pin
    Shi, Xiaozhi
    Xu, Xiangjin
    Lin, Yiyang
    Shao, Zhulin
    Wu, Rongdan
    Huang, Lihong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 173 - 182
  • [22] Effect of Liraglutide, Metformin, and Gliclazide on Body Composition in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease-A Randomised Trial
    Feng, Wenhuan
    Bi, Yan
    Li, Ping
    Yin, Tingting
    Gao, Caixia
    Shen, Shanmei
    Gao, Lijun
    Jiang, Can
    Zhu, Dalong
    DIABETES, 2018, 67
  • [23] Effect of soluble dietary fibre fraction of Trigonella foenum graecum on glycemic, insulinemic, lipidemic and platelet aggregation status of Type 2 diabetic model rats
    Hannan, JMA
    Rokeya, B
    Faruque, O
    Nahar, N
    Mosihuzzaman, M
    Khan, AKA
    Ali, L
    JOURNAL OF ETHNOPHARMACOLOGY, 2003, 88 (01) : 73 - 77
  • [24] Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers
    Abdulmalek, Shaymaa A.
    Balbaa, Mahmoud
    PLOS ONE, 2019, 14 (08):
  • [25] High prevalence of advanced NAFLD in type 2 diabetic patients with unremarkable liver enzymes and effect of liraglutide on NAFLD: meta-analysis of the LEAD Program
    Armstrong, M. J.
    Falahati, A.
    Elbrond, B.
    Schmidt, W. E.
    Gough, S.
    Newsome, P. N.
    DIABETOLOGIA, 2010, 53
  • [26] High Prevalence of Advanced NAFLD in Type 2 Diabetic Patients with Normal Liver Enzymes and Effect of Liraglutide on NAFLD: Meta-Analysis of the LEAD Program
    Armstrong, Matthew J.
    Falahati, Ali
    Braun, Oscar O.
    Schmidt, Wolfgang E.
    Gough, Stephen
    Newsome, Philip N.
    DIABETES, 2010, 59 : A411 - A411
  • [27] Effect and mechanisms of zinc supplementation in protecting against diabetic cardiomyopathy in a rat model of type 2 diabetes
    Lu, Ying
    Liu, Ya
    Li, Hongyan
    Wang, Xue
    Wu, Wenjie
    Gao, Lichao
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2015, 15 (01) : 14 - 20
  • [28] Study on the Protective Effect of Shengmai San ((sic)) on the Myocardium in the Type 2 Diabetic Cardiomyopathy Model Rat
    Ni Qing
    Wang Jie
    Li En-qing
    Zhao An-bin
    Yu Bin
    Wang Min
    Huang Chun-rong
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2011, 31 (03) : 209 - 219
  • [29] Effect of mitoquinone (Mito-Q) on neuropathic endpoints in an obese and type 2 diabetic rat model
    Fink, Brian
    Coppey, Lawrence
    Davidson, Eric
    Shevalye, Hanna
    Obrosov, Alexander
    Chheda, Pratik Rajesh
    Kerns, Robert
    Sivitz, William
    Yorek, Mark
    FREE RADICAL RESEARCH, 2020, 54 (05) : 311 - 318
  • [30] In Vivo evaluation of cinnamon bark and fenugreek seed extracts for reversing pancreatic β-Cell Dysfunction in type-2 diabetic rat model
    Nausheen, Rimsha
    Haidar, Usman
    Iftikhar, Arslan
    ACTA PHYSIOLOGICA, 2024, 240 : 59 - 60